Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soffer

Showing results (951-960 of 1,518) with videos related to

Pageof 152
Sort By:
Cancer Research|June 5, 2016
Incipient Melanoma Brain Metastases Instigate Astrogliosis and NeuroinflammationHila Schwartz, Eran Blacher, Malak Amer, et al.
Journal of Clinical Lipidology|November 13, 2024
Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North AmericaRobert A Hegele, Zahid Ahmad, Ambika Ashraf, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 12, 2022
Association of functional connectivity of the executive control network or default mode network with cognitive impairment in older adults with remitted major depressive disorder or mild cognitive impairmentNeda Rashidi-Ranjbar, Tarek K Rajji, Colin Hawco, et al.
Circulation|March 13, 2018
Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP-4 StudyFrancesco Franchi, Fabiana Rollini, Jose Rivas Rios, et al.
Archives of Neurology|April 13, 2005
Early clinical heterogeneity in choreoacanthocytosisAlexander Lossos, Carol Dobson-Stone, Anthony P Monaco, et al.
Circulation|January 12, 2019
Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionFrancesco Franchi, Fabiana Rollini, Andrea Rivas, et al.
JACC. Basic to Translational Science|June 2, 2020
Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes: Results of a Randomized Pharmacodynamic Study in a Feasibility Investigation of Rapid Genetic TestingFrancesco Franchi, Fabiana Rollini, Jose Rivas, et al.
Archives of Medical Science : AMS|September 1, 2020
Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type III hyperlipoproteinemia)Vincent A Pallazola, Vasanth Sathiyakumar, Jihwan Park, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 30, 2022
Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapyMattia Galli, Francesco Franchi, Fabiana Rollini, et al.
Thrombosis and Haemostasis|August 31, 2019
Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT StudyFrancesco Franchi, Fabiana Rollini, Emilio Garcia, et al.
Pageof 152

Showing results (951-960 of 1,518) with videos related to

Sort By:
Pageof 152
Cancer Research|June 5, 2016
Incipient Melanoma Brain Metastases Instigate Astrogliosis and NeuroinflammationHila Schwartz, Eran Blacher, Malak Amer, et al.
Journal of Clinical Lipidology|November 13, 2024
Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North AmericaRobert A Hegele, Zahid Ahmad, Ambika Ashraf, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 12, 2022
Association of functional connectivity of the executive control network or default mode network with cognitive impairment in older adults with remitted major depressive disorder or mild cognitive impairmentNeda Rashidi-Ranjbar, Tarek K Rajji, Colin Hawco, et al.
Circulation|March 13, 2018
Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP-4 StudyFrancesco Franchi, Fabiana Rollini, Jose Rivas Rios, et al.
Archives of Neurology|April 13, 2005
Early clinical heterogeneity in choreoacanthocytosisAlexander Lossos, Carol Dobson-Stone, Anthony P Monaco, et al.
Circulation|January 12, 2019
Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionFrancesco Franchi, Fabiana Rollini, Andrea Rivas, et al.
JACC. Basic to Translational Science|June 2, 2020
Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes: Results of a Randomized Pharmacodynamic Study in a Feasibility Investigation of Rapid Genetic TestingFrancesco Franchi, Fabiana Rollini, Jose Rivas, et al.
Archives of Medical Science : AMS|September 1, 2020
Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type III hyperlipoproteinemia)Vincent A Pallazola, Vasanth Sathiyakumar, Jihwan Park, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 30, 2022
Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapyMattia Galli, Francesco Franchi, Fabiana Rollini, et al.
Thrombosis and Haemostasis|August 31, 2019
Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT StudyFrancesco Franchi, Fabiana Rollini, Emilio Garcia, et al.
Pageof 152